Tag: cancer research
A new report has revealed the key breakthroughs and milestones that cancer research has achieved in the last 20 years.
Treatments for prostate cancer have a high success rate but there has been limited research into the long-term effects on survivors.
In 2019/2020, we spent a total of $19,736,934 on research across all cancer types.
WHO has launched a strategy to eliminate cervical cancer and implement national cervical cancer control plans.
This Daffodil Day, donate to support Cancer Council NSW research into reducing the impact of COVID-19 on cancer in Australia New Cancer Council NSW analysis shows the impacts of COVID-19 could cause a significant increase in the state’s cancer burden through disruptions to cancer prevention, early detection and patient care services. However, lessons from the […]
While mortality rates from all other cancers are falling or remain static, liver cancer deaths have increased at a higher rate than those of any other cancer in Australia since figures were first published from 1968. Hepatitis B and C infection are the main cause for the unprecedented increase, compounded by other risk factors such […]
In Australia, only around 10% of people diagnosed with pancreatic cancer survive for five years or more – and this rate has barely improved in the past few decades. Professor Rasko is trying to change this by researching a new treatment called CAR T-cell immunotherapy. This type of treatment involves taking a patients own […]
Last week we announced over $9 million of new funding to ground-breaking cancer research projects. The 14 world-class research teams are leading the charge towards a cancer free future by investigating new ways to diagnose and treat the disease. The projects span a range of cancers, including four low survival cancers: ovarian, stomach, liver and […]
NSW, give yourself a big pat on the back. We’re pleased to say that in 2018/19, more than 246,000 people across NSW supported people affected by cancer with fundraising activities or donations, raising almost $64 million. Thanks to our supporters’ passion, dedication and hard work, last year more than 530,000 cancer patients and their […]
Professor Jennifer Martin has been researching into personalised chemotherapy dosing for some time. Now Professor Martin and her team are moving into the trial stage of their research. The dosing study known as the PREDICT (Pathway of Research to Evaluation of Dose-Individualised Cancer Therapy) Program uses new technology to find the ideal chemotherapy dosage for […]